← FDA DRUG APPROVALS

FDA ANDA · ANDA070358

DIAZEPAM

Sponsor: ROXANE

APPLICATION
ANDA070358
TYPE
ANDA
ORIGINAL APPROVAL
2000-01-03
LATEST ACTION
2000-01-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DIAZEPAMDiscontinued
DIAZEPAM 10MG · TABLET · ORAL

Approval history

2000-01-03OriginalAP
1991-02-01Labeling · Supplement 7AP
1990-01-16Labeling · Supplement 4AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →